Generic Drugs under Medicare: Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases

Home > Diane Publishing Books >

Our Price: $25.00

By John E. Dicken (au)
Year: 2016
Pages: 52
Binding Paperback
ISBN 978-1-4578-6337-0

Product Code: 1457863375

Description

Medicare is the largest public payer for prescription drugs, representing 29% of total retail prescription drug spending in 2014. Generic prescription drugs have been a source of cost savings for the U.S. health care system due to their lower costs relative to brand-name drugs. However, recent price increases of certain generics may limit cost savings. This report describes (1) how generic drug prices under Medicare Part D have changed over time; (2) the extent to which generic drugs under Medicare Part D experienced extraordinary price increases, the persistence of any increases, and their effect on benefit design; and (3) the factors that stakeholders identified as contributing to price changes. Tables and figures. This is a print on demand report.

Share your knowledge of this product with other customers... Be the first to write a review